Medisys Project Consultants Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-06-2024
- Paid Up Capital ₹ 0.10 M
as on 24-06-2024
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -54.30%
(FY 2019)
- Profit -69.42%
(FY 2019)
- Ebitda -80.85%
(FY 2019)
- Net Worth 0.62%
(FY 2019)
- Total Assets 1.64%
(FY 2019)
About Medisys Project Consultants
The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sheeba Shamsudeen, Mohamed Shamsudeen, Shameer Deen, and One other member serve as directors at the Company.
- CIN/LLPIN
U74149DL2006PTC145048
- Company No.
145048
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Medisys Project Consultants?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shameer Deen  | Managing Director | 05-Jul-2010 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sheeba Shamsudeen | Director | 19-Jan-2006 | Current |
| Mohamed Shamsudeen | Director | 19-Jan-2006 | Current |
| Rajendran Maheswaran | Director | 01-May-2017 | Current |
Financial Performance of Medisys Project Consultants.
Medisys Project Consultants Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 54.3% decrease. The company also saw a substantial fall in profitability, with a 69.42% decrease in profit. The company's net worth moved up by a moderate rise of 0.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medisys Project Consultants?
In 2018, Medisys Project Consultants had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mednext Academy Private LimitedActive 3 years 4 monthsMohamed Shamsudeen and Shameer Deen are mutual person
- Meditrust Hospitals And Research CentreActive 12 years 9 months
Mohamed Shamsudeen and Shameer Deen are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medisys Project Consultants?
Unlock and access historical data on people associated with Medisys Project Consultants, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medisys Project Consultants, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medisys Project Consultants's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
